The national drug pricing regulator NPPA has fixed the retail and ceiling prices of 22 formulations used for treatment of various ailments including HIV, bacterial infections and cardiac conditions among others.
FDA Confirms Paragraph IV Patent Challenge of Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate)